Unit-Dose Respiratory Medications Market Insights, New Innovations, Research and Growth Factor till 2028

Unit-Dose Respiratory Medications Market: OverviewUnit-dose respiratory medication market is expected gain substantial growth over the forecast period due to rising demand of unit dose dispensing system in the hospital. Leading manufacturer unit-dose respiratory medication are emphases on continuous launches of more compatible medication with nebulizer. By route of administration, unit-dose respiratory medications market is classified as oral and parenteral. Oral segment by route of administration is expected to gain majority of market share by revenue though it is more preferred by physician and nurses. Among, all end user hospital is anticipated concentrate revenue share for unit dose dispensing market which is then followed by ambulatory surgical centres. By end user, specialty clinics is projected grow at grater pace than other segment.

Unit-dose respiratory medications are generally used with nebulizers and other devices to treat respiratory disease disorders. Unit dose respiratory medications can be administered through oral parenteral and respiratory route of administration. Unit-dose dispensing medication is the ready package for the patients. There are many variation of unit dose dispensing system. For instances, when doctor order medication for the patient in hospital it went to the central pharmacy. Pharmacist revive this order and sent the medication in the unit dose cart. A pharmacist usually sent one drawer for each patient. These drawer are labelled with patient name, bed number and ward room number and also the medication inside the drawer. Once, all the medication is given to the patient by the nurse or the ward attendant, this cart is again retrieved from the ward and it is replaced by fresh and updated medication.

Unit-Dose Respiratory Medications Market: Drivers and Restraints

Increasing number of the respiratory disorder is the primary factor driving the growth of unit dose respiratory medication market. Moreover, rising adoption unit dose medication and increasing preference by the nurse to have unit dose medication in the hospital will propel the growth of Unit-Dose Respiratory Medications market. Unit dose respiratory medication avoids the complication during the treatment of the respiratory disorder which leads to the increased demand for unit dose dispensing respiratory medication. Stringent regulatory scenarios by the US FDA and industry compliance will lead to substantial growth of Unit-Dose Respiratory Medications market. Addition, lack of availability of healthcare infrastructure in under developing economies will also deter the growth of this unit dose respiratory medication market over the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6871

Unit-Dose Respiratory Medications Market: Regional Outlook

Geographically, global unit-dose respiratory medications market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China and Japan, China, Japan, Middle East and Africa. North America is expected to account for the maximum market share in global Unit-Dose Respiratory Medications Market due to high adoption of unit dose dispensing system in this region.  Western Europe is expected to be the second largest market generating decent demand for unit-dose respiratory medication. China and Japan are expected to emerge at the fastest pace over the forecast period. On the background of an expanding market in developing Asia Pacific region, growing medical tourism will continue to fuel the market for unit-dose respiratory medication in India, which currently leads the APECJ market. Latin America and MEA unit-dose respiratory medication markets are expected to witness delayed growth over the forecast period.

Unit-Dose Respiratory Medications Market: Key Players

Some of the players identified in global Unit-Dose Respiratory Medications Market include Smiths Medical, Cardinal Health, Nephron Pharmaceuticals Corporation and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan and China (India, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC, South Africa, Rest Of MEA)

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6871

Unit-Dose Respiratory Medications Market: Segmentation 

Global Unit-Dose Respiratory Medications market has been segmented on the basis of route of administration, end user, and geography.

Based on route of administration, global unit-dose respiratory medications market is segmented as below:

  • Oral
  • Parenteral

Based on end user, global unit-dose respiratory medications market is segmented as below:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

Severe Acute Respiratory Syndrome Treatment Market Growth Analysis, Opportunities, Trends, Developments, And Forecast to 2028

The severe acute respiratory syndrome is caused by the coronavirus which is found in bats and palm civets in Southern China. The severe acute respiratory syndrome is a serious life-threatening viral infection. Its symptoms includes cough, chills and shaking, headache, muscle aches, diarrhoea, nausea, vomiting and dizziness. The severe acute respiratory syndrome first appeared in 2003 and spread rapidly. This infection can spread easily from one person to another via respiratory droplets if they come in contact with skin or mucous membranes. In October 2012, the severe acute respiratory infection was added to National Select Agent Registry, which regulates the handling and control of bacteria, viruses and toxins that have the capability to pose a severe risk to public health and safety. Risk of atypical pneumonia, pulmonary fibrosis and respiratory failure are the major risk factors associated with the severe acute respiratory syndrome. Antivirals and antibiotics are recommended for treatment of severe acute respiratory syndrome. However, an antibiotic treatment, in most cases, is not enough to treat severe acute respiratory syndrome treatment; supportive care is also required.Severe Acute Respiratory Syndrome Treatment Market: Drivers and Restraints-

Risk factors associated with the spread of severe acute respiratory syndrome include increasing recommendation for combination therapy drugs and increasing prevalence of infectious diseases. These factors will drive the growth of the severe acute respiratory syndrome treatment market. 90% cases of severe acute respiratory syndrome in developing countries and increasing complication rate due to pneumonia and respiratory failures will propel the growth of the severe acute respiratory syndrome treatment market during the forecast period. Increasing research and development and clinical trials and usage of therapeutics for severe acute respiratory syndrome treatment will propel the growth of severe acute respiratory syndrome treatment market. Government initiatives to reduce mortality rate will also be a major factor which will contribute to the growth of the severe acute respiratory syndrome treatment market.

Severe Acute Respiratory Syndrome Treatment Market: Overview

Severe acute respiratory syndrome treatment therapeutic drugs involve a broad-spectrum of antibiotics and supportive care as well as immunomodulatory therapy and antiviral agents. Some antibiotics have immunomodulatory properties. For instance, quinolones and macrolides are prescribed for severe acute respiratory syndrome treatment. The Ribavirin antiviral drug was majorly chosen as an empirical therapy for severe acute respiratory syndrome. It is the most commonly used antiviral with corticosteroids. Corticosteroids have been the main immunomodulatory therapy used for severe acute respiratory syndrome treatment. Thymosin alpha 1 is also administrated to treat severe acute respiratory syndrome treatment, especially in China. Thymosin alpha 1 is a relatively safe product and enhances T-cell function.

Severe Acute Respiratory Syndrome Treatment Market: Region-wise Outlook

In terms of geography, the severe acute respiratory syndrome treatment market has been divided into seven regions — North- America, Eastern Europe, Western Europe and Asia- Pacific excluding China & Japan (APECJ), Japan Middle-East & Africa and Latin America. North America is the dominating segment in the severe acute respiratory syndrome treatment market due to rising awareness regarding infectious diseases and increasing drug manufacturing facilities. In Western Europe, Germany, France and the UK will be the fastest growing regions in the severe acute respiratory syndrome treatment market due to strengthening laws and government guidelines covering infectious diseases. APEJ region includes two fastest developing countries — India and China — which will prove to be the most promising markets for severe acute respiratory syndrome treatment market players due to factors like increasing government initiatives to reduce disease complication and high incidences of diseases in China.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-6866

Severe Acute Respiratory Syndrome Treatment Market: Key Market Participants

Example of some key market participants in the global severe acute respiratory syndrome treatment market are Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC., Reckitt Benckiser Group plc, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Merck & Company, Inc., Abbott Laboratories and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-6866

Severe Acute Respiratory Syndrome Treatment Market: Segmentation

On the basis of drug type, the severe acute respiratory syndrome treatment market can be segmented into:

  • Antiviral
  • Antibacterial
  • Immunomodulators drugs

On the basis of route of administration, the severe acute respiratory syndrome treatment market can be segmented into:

  • Oral
  • Injectable

On the basis of distribution channel, the market can be segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6866

Oligonucleotide API Market to Reach US$ 4 Billion, Globally, by 2030at 11% CAGR: FMI

According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 3 Bn in 2020, and witness a CAGR of 11% through 2030.

According to FMI’s analysis, as of now, 100+ oligonucleotide APIs are in the clinical trials’ phase, and regulatory approval is on the cards. Post-approval, the demand for production capacity will witness an exponentiation, thereby driving the oligonucleotide API market through 2030.

Oligonucleotides are being looked upon as the subsequent large group of therapeutics following biologics and molecules. This could be attributed to the assurance on their part to develop drugs at lower costs.

Apart from immune therapy, microbial and cardiovascular infections, and cancer, oligonucleotide APIs are being tried out to treat neurological disorders like Alzheimer’s as well. However, factors like regulatory complexities and timely delivery of oligonucleotides (amidst Covid-19) are acting as restraints.

The top 5 Key players in oligonucleotide API market include:

  • Sarepta Therapeutics,
  • Akcea Therapeutics,
  • Jazz Pharmaceuticals, Inc.,
  • Biogen,
  • Dynavax Technologies.

The players are focusing on enhancing their regional and global presence in the enterprise solutions through inorganic growth strategies. At the same time, new product launches have been on the anvil.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11933

For instance –

  • Biogen, Inc., in May 2019, put forth interim results of phase I/II study with respect to tofersen for treating ALS (amyotrophic lateral sclerosis). Tofersen is an antisense oligonucleotide (ASO).
  • Dynavax, in the year 2017, launched Heplisav-B at the commercial level. It is a 1-month, 2-dose adult Hepatitis B vaccine.
  • In 2017, GE’s Dharmacon business partnered with CordenPharma International for creating end-to-end oligonucleotide APIs-based drugs.

Key Takeaways from Oligonucleotide API Marker Study

  • Antisense Oligonucleotides APIs are anticipated to reach US$ 4 Bn by 2030.
  • North America and Europe collectively accounted for more than 47% of revenue share in 2019 while Asia Pacific is expected to grow at the fastest rate in the forecast period.
  • Increase in use of antisense oligonucleotide APIs (especially post approval from US FDA in 2016) to boost the market in the forecast period

New Product Launches: Key Indicators to Oligonucleotide APIs Market

FMI has analyzed players such as Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Dynavax Technologies in this report. According to the analysis, these players are consolidating their positions through new product launches.

For instance –

  • In Mar 2020, Dynavax entered into collaboration with Clover Biopharmaceuticals for developing a vaccine candidate to combat Covid-19. Clover is into advanced evaluation of its Covid-19 S-Trimer, protein-based coronavirus vaccine candidate and Dynavax has its technical expertise along with proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 for executing this.
  • Alnylam Pharmaceuticals, Inc., in 2018, launched Givlaari and Onpattro at the commercial level.

Gene Therapy and Oligonucleotide APIs

Synthetic oligonucleotides are being used in gene therapy for inactivating genes that help in propagating the disease. Antisense oligonucleotide APIs are used for disrupting the faulty gene’s transcription.

Also, siRNA could be used for signaling the cell to disrupt faulty mRNA’s translation. Along these lines, Pharmamar, in Jan 2020, signed an agreement with Jazz Pharmaceuticals for selling the API for “lurbinectedin”, one of the late-phase treatments for SCLC (small cell lung cancer) so that the latter could commercialize it.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-11933

Want more insights?

The study provides compelling insights on Oligonucleotide API market on basis of API type in detail cover every aspects of the market such as Antisense Oligonucleotides API, Short Interfering RNA (siRNA) API, Phosphorodiamidate Morpholino Oligonucleotides (PMO) API, MiRNA API, Aptamers API, CpG Oligonucleotides API  and Others (ON Conjugates (NP), ShRNA, etc.), Marketing Status (Marketed, Clinical Trials (Clinical Phases)), and end users (Pharmaceutical Companies  and Biotechnology Companies)) across seven major regions.

Oligonucleotide API Market: Segmentation

API Type

  • Antisense Oligonucleotides API
  • Short Interfering RNA (siRNA) API
  • Phosphorodiamidate Morpholino Oligonucleotides (PMO) API
  • MiRNA API
  • Aptamers API
  • CpG Oligonucleotides API
  • Others (ON Conjugates (NP), ShRNA, etc.)

Marketing Status

  • Marketed
  • Clinical Trials (Clinical Phases)

End User

  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11933

Manual Resuscitator Market is expected to witness a CAGR of over 4.1% between 2020 and 2030

The global manual resuscitator market is set to surpass a valuation of USD 500 million by 2030, according to a research by ESOMAR-certified firm Future Market Insights (FMI). In a new study on the market, the

COPD (chronic obstructive pulmonary disease) is amongst the most life-threatening diseases, wherein breathlessness forms the very first symptom. The WHO states that the number of people affected by COPD crossed 250 Mn in 2019.

The US alone has more than 15 Mn cases (as per the American Lung Cancer Association). There isn’t any direct cure on records as of now. As such, symptomatic treat is being administered.

According to FMI’s analysis, manual resuscitator is sufficing at the moment. However, automation in this regard is bound to restrain the market in the years to come.

Manual Resuscitator Market Outlook and Key Findings

  • The global manual resuscitator market is expected to witness a CAGR of over 4.1% between 2020 and 2030
  • North America and Europe collectively account for more than 50% of market share and the scenario is expected to remain the same in the years to come.
  • Outbreak of Covid-19 has resulted in more than 60% of growth since Mar 2020
  • Automation of manual resuscitators is expected to restrain the market in the near future

To remain ‘ahead’ of your competitors, request for a sample

What’s with Infants and Neonates?

According to the WHO, in the year 2018, close to 2.5 Mn children died in the very first month of their life due to pre-term birth, infections, or birth asphyxia.

It further states that around 23% of infants were diagnosed with birth asphyxia in the same year. Resuscitation is a must in cases like these.

The trend mentioned above, apart from COPD, is expected to take the manual resuscitator market at a higher stride in the forecast period (2020-2030).

Key Takeaways

  • Self-inflating bags accounted for the highest market share in 2019 as the usability is greater in emergency situations. Also, NCBI states that neonatal care could be best adhered to through self-inflating bags.
  • Flow-inflating bag (better known as anaesthesia bag) is expected to witness an exponential growth between 2020 and 2030 as it finds its applications in intensive care units, wherein even a bit of fluctuation in oxygen delivery is uncalled for.
  • Out-of-hospital cardiac arrests have been increasing worldwide. Around 395,000 such cases are seen in the US alone every single year. The National Academies of Sciences, Engineering and Medicine (US) has been conducting public workshops for improving strategies to survive cardiac arrests. This will also drive the demand for manual resuscitators as the primary course of treatment.
  • The outbreak of Covid-19 has escalated the demand for manual resuscitators as breathlessness is one of the symptoms herein.

“Neonatal Care is the primary area of focus by the governments worldwide, along with heart-related ailments. This trend is bound to bolster the manual resuscitation market in the forecast period” – says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2284

Key Participant Insights

The global market is set to enhance its scope in the forecast period, due to rising number of cardiac arrests. In addition to this, cost-effectiveness is augmenting the sales of manual resuscitator.

The key market players covered by FMI include HUM Systems for Life, GE Healthcare, Covidien Plc, Hopkins Medical Product, Drager Medical AG and Co., Laerdal Medical, Me. Ber. Srl, Hill, Ambu A/S, Philips Healthcare, CareFusion, Weinmann, and Medline Industries.

Key Segment

Type

  • flow-inflating resuscitator
  • self-inflating resuscitator
  • T-piece

Modality

  • Silicone
  • PVC
  • rubber

Technology

  • pop-off valve
  • PEEP valve
  • others

Type of Patient

  • Pediatric
  • Adult
  • Others (Neonates and Infants)

End-Use

  • hospital
  • out-of-hospital (home care, community care, primary care)
  • ASC
  • Military
  • others (specialized diagnostic centres, specialized clinics)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2284

Geography

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Veterinary Imaging Market revenues will reach US$ 3.37 Billion by 2030

Global veterinary imaging market revenues will reach US$ 3.37 Bn by 2030, according to a study by Future Market Insights (FMI). The research study analyzes veterinary imaging market growth through 2030, in over 20+ countries. The study also offers incisive insights on key strategies of some of the leading players in the market.

According to the study, veterinary diagnostics market is witnessing investments, as pet humanization trend gains traction. Growing focus and government mandates on maintaining animal health is also likely to provide a boost to market growth.

The growth of the animal and pet care category as a whole will also spur growth. According to estimates from NAPHIA, the spending on pet food, pet insurance, and pet therapeutics have witnessed an increase in the recent past. The pet food category has in fact grown despite the Covid-19 crisis.

The broader gains in this market are likely to rub off on veterinary imaging market as well during the assessment period.

A Step Towards Better Future

In Aug 2020, the Veterinary Summer Scholars Symposium was held, which included 500+ veterinary students from all across the US, along with animal health leaders and researchers from close to 36 top veterinary schools.

This yearly scientific colloquium showcases research conducted by veterinary students who are on the verge of completion of summer research internships. Such symposiums are likely to compel more millennials to take up veterinary science in the due course of time.

“Technological advancements along with inorganic expansion are creating new strides for the veterinary imaging market. These trends are bound to catapult the veterinary imaging market to growth between 2020 and 2030”- says the FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12368

Key Takeaways

  • Animal healthcare being a costly affair, people are shifting their gears to pet insurance
  • The veterinary imaging market is driven by an ever-increasing number of veterinarians adopting imaging devices with reagents associated with them, which include PET, MRI, X-Ray radiology devices, and CT scanners
  • Multi-slice CT scan systems expected to drive the market in the forecast period
  • Asia-Pacific is slowly picking up with people turning the tide in favour of pet care
  • Adoption of magnetic resonance imaging (MRI) systems continue to grow at a steady pace

Key Participant InsightsThe key market players are emphasizing on creating awareness about veterinary imaging devices to enter the untapped markets. For instance – in Oct 2018, GE Healthcare announced having inked a strategic agreement with SonoSim for encouraging training regarding ultrasound services.

The other players in the veterinary imaging market include Diagnostic Imaging System, Inc., Merry X-Ray, Carestream Health, Heska Corporation, Fujifilm Holding Corporation, Medical Imaging/IMCO, Inc., BCF, Esaote SpA.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global veterinary imaging market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on veterinary imaging market on the basis of product type (Equipment (Radiography (X-ray) System (Computed Radiography, Film-based Radiography)), Ultrasound Imaging System (2D US Imaging, 3D US Imaging), Magnetic Resonance Imaging System, Computed Tomography System (Single Slice CT, Multi-Slice CT), Video Endoscopy Imaging System, and Others)), Software, and Imaging Reagents (Ultrasound Contrast Reagents, MRI Contrast Reagents, X-Ray/CT Contrast Reagents, and Nuclear Imaging Reagents), application (Cardiology, Orthopedic, Neurology, Oncology, and Others), animal type (small animal, large animal), end-user (Veterinary Clinics, Veterinary Hospitals, and Veterinary Institutes and Research Centers) across seven geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12368

Key SegmentProduct Type

  • Equipment
  • Software
  • Imaging Reagent

Application

  • Cardiology
  • Orthopedics
  • Neurology
  • Oncology
  • Others

Animal Type

  • Small Animal
  • Large Animal

End-User

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Institutes and Research Centres

Geography

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12368

Superficial Radiation Therapy Market Top Key Company Profiles – Sensus Healthcare, Inc., SkinCure, Mevion Medical Systems, Varian Medical Systems Inc., Ion Beam Applications, RaySearch Laboratories

The global superficial radiation therapy market will reach US$ 57.3 Mn by 2030, according to a new report by ESOMAR-certified market research firm, Future Market Insights (FMI).

Superficial radiation therapy systems are being widely used  as they prove to be an efficacious and non-invasive option with regards to skin treatment.

Also, superficial radiation therapy systems, based on almost negligible risks on the count of post-surgery infections and loads of other complications, are likely to gain further adoption in the future.

Consistency in terms of innovation has been the key focus area of the market players. For instance, Sensus Healthcare, in 2018, did install its SRT-100 system at “Hillcrest Plastic Surgery” in Orlando, Florida.

Keloid scars are being treated through this SRT-100. As an outcome of preference to these non-invasive procedures, the superficial radiation therapy systems market is expected to gain maximum mind share in the forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5279

Key Takeaways

  • The global superficial radiation therapy systems market is expected to reach US$ 39.7 Mn in 2020.
  • Ambulatory surgical centers are adopting superficial radiation therapy systems at a brisk pace
  • Curative treatment to lead the superficial radiation therapy systems market in the forecast period
  • Cancer treatment to tilt in favour of non-invasive treatment, which will ask for more innovations herein.

“Innovations on the consistent basis have been keeping the cash registers ringing. This trend is expected to propel the superficial radiation therapy systems market between 2020 and 2030” – says the FMI analyst.

Key Participant Insights

The global market is set to witness steady growth through 2030.

In addition to this, exploration of superficial radiation therapy systems for the other types of cancers like breast cancers (apart from skin cancers) is expected to drive the market.

The key market players covered by FMI include Sensus Healthcare, Inc., SkinCure, Mevion Medical Systems, Varian Medical Systems Inc., Ion Beam Applications, RaySearch Laboratories, Elekta AB, Mitsubishi Electric Corporation, IsoRay Inc., Xstrahl Ltd., and Nordion Inc.

At the same time, there is a dearth of medical professionals performing superficial radiation therapy with utmost precision. This factor is likely to hamper the market.

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global superficial radiation therapy systems market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on superficial radiation therapy systems market on the basis of product type (superficial radiation therapy systems, software), application (Basal Cell Carcinoma, Squamous Cell Carcinoma, Keloid scars, Psoriasis, Kaposi Sarcoma (Plaque Stage), Bowen’s Disease, Cutaneous T-cell Lymphoma, Soft Tissue Metastases), end-user (hospitals, ASCs (Ambulatory Surgical Centres), cancer research institutes, dermatology centres) across seven major regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5279

Key Segment

By Product Type

  • Superficial Radiation Therapy Systems
  • Superficial Radiation Therapy Software

By Application

  • Basal Cell Carcinoma
  • Squamous Cell Carcinoma
  • Keloid Scars
  • Psoriasis
  • Kaposi Sarcoma (Plaque Stage)
  • Bowen’s Disease
  • Cutaneous T-cell Lymphoma
  • Soft Tissue Metastases

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Dermatology Centers

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/5279

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Patient Lateral Transfer Market is expected to reach US$ 519.3 Million by 2030

As per FMI – an ESOMAR-certified market research firm, the global patient lateral transfer market is expected to reach US$ 519.3 Mn by 2030.

The likelihood of patients moving and getting lifted from stretchers or bed causing back injuries, strain to caregivers and healthcare workers owing to forceful exertion, repetitive movement, and awkward posture can’t be ruled out. Patient lateral transfer devices come to the rescue over here.

Patient lateral transfer devices lessen friction during transfer of patients and prove to be equally beneficial for patients.

Key Takeaways

  • Air-assisted transfer devices held the largest market share in 2019 and the winning streak is expected to continue in the forecast period
  • Asia-Pacific is looked upon as a promising market due to growing awareness about the need for patient lateral transfer devices along with improvement in healthcare infrastructure
  • Covid-19 to escalate the market in the year 2020, and further traction expected with the onslaught of chronic devices
  • Individual product promulgation is a key trend observed in the market

“The patient lateral transfer market is subject to exclusive branding by the key players. This trend coupled with the outbreak of Covid-19 is expected to propel the market in the forecast period” – FMI analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12381

Key Participant Insights

The global patient lateral transfer market exhibits higher growth potential along with key players projecting their brands. The competitive factors include product differentiation, technology, and competitive pricing.

For instance – McAuley Medical’s Gold Rollboard, Patient Mover Slide Boards, and Handy Rollerboard Accessories, HoverMatt Air Transfer System from HoverTech, Himm-Rom’s HandyTube Manual Transfer Aid and Patient Transfer Board are doing the rounds at present.

The other players are also in the race. As such, there exists fierce competition over here. If players opt for partnerships/joint ventures, the competitive landscape would take a cutting-edge turn.

The players in the patient lateral transfer market include McAuley Medical, Inc., Patient Positioning Systems LLC, HoverTech International, Stryker Corporation (Sage Products LLC), Getinge AB (ArjoHuntleigh), EZ Way, Airpal, Inc., Arjo, Medline Industries, Haines Medical Australia, Sizewise, and Prism Medical.

FMI’s report offers incisive insights on the key strategies of leading and tier II patient lateral transfer market players. A detailed analysis of business and product strategies is offered in the report.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global patient lateral transfer market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on patient lateral transfer market on the basis of product type (air-assisted transfer devices, slide sheets, and transfer accessories), usage type (single patient use, reusable), end-users (hospitals, clinics, ASCs) across seven regions.

Patient Lateral Transfer Market: Segmentation

The global Patient Lateral Transfer Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • air-assisted transfer devices
  • slide sheets
  • transfer accessories

Usage Type

  • single patient use
  • reusable

End-user

  • Hospitals
  • Cllinics
  • Ambulatory Surgical Centres

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12381

Geography

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Parchment Paper Market to Garner Brimming Revenues by 2031

Parchment paper usage has caused a significant reduction in sales for clamshell boxes through the food industry. To decrease the global carbon footprint and its impact, key players have started adopting greener ways for working towards environment compliance. As per FMI analysis, sales are expected to surge at 5.8% CAGR between 2021 and 2031. Thanks to expansion of food service sector, the market is forecast to surpass a valuation of US$ 1.6 Bn by 2031.

Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-5776

Parchment paper consumption has risen in the last decade through rising application in bakeries, restaurants, packed food, food deliveries, and take-away. Moreover, stringent environment rules are being applied across many countries to reduce dependency on non-biodegradable materials, combining all these, sales of parchment paper are anticipated to witness significant surge during the forecast period.

Georgia-Pacific Corp., METSA Tissue, Ahlstrom-Munksjo Oyj. are the top players operating in the parchment paper market. Furthermore, Delfort Group AG, Cosmoplast, JK Paper, Nordic Paper and Kalpataru Papers LLP are also the noticeable players in the parchment paper market. The Tier 3 players in the market hold 70-75% in the global parchment paper market. In conclusion, key players contribute almost 25-30% of the global market.

FMI forecast has that the future demand and sales of parchment paper will be definite and will continue increasing. Factors such as increase in middle class family income, environmental regulations, convenience factor, coupled with advancements in recycling processes will exponentially increase the parchment paper sales globally.

“The consumption of ready to eat products and fast foods is rising globally. Increasing application in the food and food services has created opportunities for parchment paper manufacturers to maximize their sales. Increasing emphasis on safe and recyclable paper is anticipated to redefine the parchment paper market growth” says FMI analyst.

Request Advisory : https://www.futuremarketinsights.com/request-advisory/rep-gb-5776

Key Takeaways from Parchment Paper Market

By product type, unbleached paper segment is ahead and leading the market. With its sustainability and recyclable nature, the segment is anticipated to hold more than 55% market share during the forecast period.

On basis of basis weight, 40-60 GSM is most preferred in the market due to its durability, safety and hygienic properties. The segment is anticipated to increase 1.97 times during next 10 years.

Among end users, ready-to-eat meal segment will witness an incremental rise of US$ 293 Mn, due to rise of disposable income of middle class families in emerging economies.

Sales in the U.S. is expected to surge at a steady rate, accounting for over 75% of the North America market in 2021.

While China is expected to remain the leading market in East Asia, thanks to expansion of food service sector, growth in South Korea will unfold at a greater pace.

How will Expansion of Food Service Industry Fuel Demand for Parchment Paper in India?

India will hold share of more than 24% for the South Asia parchment paper market by the end of year 2031. The expansion of the food services will present lucrative opportunities for parchment paper manufacturers to maximize their sales in India.

Focus on Sustainable Packaging Solutions Augmenting Parchment Paper Sales

Parchment papers are primarily used to pack food products without hampering the product quality. Parchment paper as a packaging solution is the most efficient way of packing food products to be delivered or stored over a period of time without disrupting the shelf-life of the product.

In the last decade, the popularity of parchment paper has reached new heights. It has emerged at a convenient option for working families to store food. Technological advancement associated with parchment paper is one of the key factors that has raised the bar parchment paper as a packaging solution.

Impact of COVID-19 on Parchment Paper Market

Global crisis of COVID-19 pandemic had negative impact on the sales of parchment paper. Lack of availability of raw pulp and paper materials in paper mills has halted the manufacturing process of parchment paper. Lockdown in t regions such as Oceania, Europe, South & East Asia and North America has induced considerable impact on the manufacturing of parchment paper.

Request Special Price : https://www.futuremarketinsights.com/request-special-price/rep-gb-5776

Key Questions Answered in the Report What is the Current Valuation of Parchment Paper Market?

The parchment paper market is expected to surpass a valuation of US$ 959.3 Mn by 2021.

At what rate did the Parchment Paper Market Expand in the last 5 years?

The parchment paper market exhibited steady CAGR of 3.3% in the last five years from 2015 to 2020.

What is the Demand Outlook for Parchment Paper Market?

Parchment paper market will register gradual rise in demand after a period of decelerating sales amid COVID-19 in 2020. As per FMI, the market will register a CAGR of 5.8% between 2021 and 2031.

What are the Key Trends Prevailing in the Parchment Paper Market?

Key parchment paper manufacturers are making solutions available that will help industries to eliminate the risk of food poisoning. Also there is high focus on production of sustainable yet greener packaging solution.

 

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Intelligent Packaging Market Study: An Emerging Hint of Opportunity by 2031

Intelligent packaging market revenue totaled US$ 17.8 Bn in 2020, according to Future Market Insights. The overall market is expected to reach US$ 46.7 Bn by 2031, expanding at a CAGR of 9.0% for 2021-31.

Worldwide sales of intelligent packaging is expected to grow by 10.5% in 2021. Surging demand for interactive packaging/ data carriers will remain a chief growth driver through the assessment period.

Get Sample of the report : https://www.futuremarketinsights.com/reports/sample/rep-gb-13604

Packaging has consistently improved in the last few years. Packaging technology has become smarter to  act as a catalyst for improving the shelf life of the packed products. Intelligent packaging is the amalgamation of technology and packaging that offer smarter and more convenient solutions.

Investments in intelligent packaging by food and beverage manufacturers have been aiding the overall expansion of the market. With the ongoing research on nanotechnology and machine learning, the intelligent packaging industry is expected to witness launch of ground-breaking packaging designs.

As per FMI, the food and beverage sector, followed by the healthcare sector are listed as top-tier investors in intelligent packaging technology.

Market Landscape

Amcor plc, Crown Holding Inc., 3M Company, CCL Industries Inc., Huhtamaki Global, DS Smith, Avery Dennison Corporation, Honeywell International Inc., Tetra Pak International S.A., Sealed Air Corporation, Stora Enso Oyj, WestRock Company, Ball Corporation and Mondi Plc, among others are some of the intelligent packaging manufacturers in the global market.

Timestrip UK Ltd., Varcode, Ltd., Temptime Corporation, DeltaTrak, Inc., EVIGENCE SENSORS, JRI Company, Vitsab International AB, LAXCEN TECHNOLOGY INC., APK-ID, STARNFC Technologies Ltd. are some of the technology manufacturers in the intelligent packaging market.

Intelligent Packaging Market- Key Takeaways

  • By technology, interactive packaging/ data carriers are expected to attract an investment opportunity of above US$ 13.3 Bn during the research period of 2021-2031 due to improved usage of QR code labels, RFID tracking and product identification barcodes among others.
  • By the level of packaging, primary packaging is expected to observe an incremental growth of 2.5x by 2031.
  • By application, blister packaging is expected to witness a YoY growth of 13.9% in 2021 due to improved usage in the pharmaceutical and healthcare industry.
  • By end-use, more than 1/3rd of the total intelligent packaging market is held by the food and beverage industry, however, the healthcare sector is expected to register a CAGR of 11% during the forecast period.
  • By region, South Asia is expected to attract intelligent packaging investors and the market is expected to account for nearly 13% of the total market share by 2031. However, Europe tops the leaderboard and is expected to showcase high demand for disruptive technologies in the intelligent packaging market.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-13604

“Intelligent packaging is headed towards providing seamless tracking and tracing, extending shelf life, monitoring and communicating product condition and interacting with the consumer through data-carrying wireless technology. The intelligent packaging market holds immense potential and investment opportunities. It will continue driving consumer engagement in the coming years,” says an FMI analyst.

Technological Advancements in Food and Beverage Packaging to Pave Way for Intelligent Packaging

Intelligent packaging was incorporated primarily for the food industry and it has seen continuous innovations in the sector since its advent. Freshness and temperature indicators to determine the product condition, QR codes and barcodes to share product information with the consumers, and moisture and oxygen scavengers to enhance the shelf life of the product were a few innovations that have changed the traditional food packaging.

The sector is expected to witness more dynamic changes and sustainable innovations due to intelligent packaging that will reshape the food packaging industry. Biosensors for pathogens and toxicity indicators are a few advances in intelligent packaging that are expected to thrive in the food and beverage packaging industry in this decade.

Another development in intelligent packaging is to uncover if the food and beverage packed within is baked or microwaved products. Researchers are developing indicators that can determine the food quality and readiness to eat with forestalling elements like microwave doneness indicators (MDIs) and colour indicators.

Smart Packaging for Tracking and Tracing Packages

Intelligent packaging uses technologies such as barcodes, NFC and RFID tags to track products and ensure they are delivered in an appropriate condition. The advent of IT software like the internet of things, blockchain technology and cloud computing are bringing a revolution in intelligent packaging by providing statistical and quantitated information about the package.

The expansion of the intelligent packaging industry is expected to boost manufacturing company offerings with better packaging designs. Consumers are looking for smart, cost-effective, aesthetically pleasing and practical intelligent packaging that is sustainable. Manufacturers are continuously replacing traditional plastic packaging with technologically-equipped paper and bio-based packaging that provides more than just product storage.

Purchase the Report : https://www.futuremarketinsights.com/checkout/13604

Impact of COVID-19 on Intelligent Packaging Market

Unlike the majority of industries affected negatively by the outbreak of COVID-19 in 2020, the global pharmaceutical and healthcare sector observed high growth and silent innovations. With the increasing manufacturing of oxygen cylinders to transporting vaccines, intelligent packaging played a vital role in shaping the industry. Intelligent packaging ensured a better product reach and safety of consumers through technologically-embedded labels, tags and cold chain packaging sensors.

The pandemic could be held responsible for the penetration of intelligent packaging in the healthcare and pharmaceutical sectors. However, limited marketing and branding options also encouraged food and beverage manufacturers to smartly advertise their products via packaging. With instruction manual to social message during the pandemic, everything was conveyed through smart packaging to the customers.

Hence, COVID-19 couldn’t be termed exactly detrimental for the intelligent packaging industry. However, with manufacturers trying to attract customers after the pandemic, intelligent packaging is expected to play a major role in shaping the consumer packaging industry.

Foam Cooler Box Market Latest Advancements and Business Opportunities 2031

As per Future Market Insights (FMI), sales of foam cooler boxes are set to expand by 1.9X between 2021 and 2031. Burgeoning demand for temperature-controlled packaging products is resulting in increased sales of foam cooler boxes.

Following the outbreak of COVID-19, pharmaceutical supplies and food & beverages products witnessed skyrocketing demand. In response to this, the consumption of temperature controlled packaging products escalated during the FQ-20.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-13962

Increasing development of vaccines, lifesaving drugs, and other essential pharmaceutical ingredients improved the demand for temperature-controlled products for safe transportation. Hence, the outbreak of COVID-19 and need for safe packaging solutions have stimulated the demand for foam cooler boxes.

Rising awareness regarding preservation of food items to increase their shelf lives and decrease the overall wastage is encouraging manufacturers to opt for foam cooler boxes. Improper storage and transportation facilities might results in damaged food products, causing losses in the food industry.

As consumers are demanding fresh food to be delivered to their doorsteps, leading food brands and suppliers are increasing the adoption of foam cooler boxes to offer a longer shelf life.

Foam cooler boxes will therefore remain highly sought-after for packaging in dairy products, frozen meat, seafood and other such items including fruits & vegetables.

Key Takeaways from Foam Cooler Box Market
  • The foam cooler boxes having a capacity of above 150 Quart are anticipated to register growth at 8.1% CAGR between 2021 and 2031.
  • Large-sized foam cooler boxes are gaining traction among exporters and supply chain partners, due to a decrease in overall transportation and packaging costs incurred by key end-users.
  • Presence of leading pharmaceutical companies along with increasing production of COVID-19 vaccines in the U.S. are accelerating demand for foam cooler boxes. The U.S. is projected to offer a total incremental opportunity of US$ 211 Mn over the upcoming decade.
  • Sales of foam cooler boxes made up of polyurethane are estimated to grow by 1.9X compared to 2020 market value over the forecast period.
  • Germany will account for 15.3% of total sales of foam cooler boxes across the Europe foam cooler box market.
  • In terms of end-use, pharmaceutical industry offers incremental opportunity of US$ 704 Mn between 2021 and 2031.

“Surging adoption of frozen food items and focus on development of pharmaceutical drugs are stimulating the demand for foam cooler boxes across the globe. Manufacturers are offering disposable and re-usable product options for foam cooler boxes, creating billion dollar sales opportunities in the market,” says FMI analyst.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-13962

Foam Cooler Box Market Landscape

Some of the key players operating in the global industrial packaging market are Yeti Coolers, LLC, Igloo Products Corporation, The Coleman Company, Inc, Sonoco ThermoSafe, Cool Ice Box Co Ltd, Coldchain Technologies, Inc, Plastilite Corporation, Pelican Products, Inc., MacNeill Pride Group (ORCA), Bison Coolers, RTIC Outdoors LLC, Koolatron US, Aohong Industry Co., Ltd., Rodman Plastics Company Ltd., and Carris Pipes & Tubes Pvt. Ltd.